HIGHLIGHTS
- who: . and collaborators from the National Technical University of Athens, Greece have published the Article: Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial brillation: A nationwide cohort study, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in direct head-tohead comparisons with VKAs and between individual NOACs in unselected patients with AF on a full-population scale from 2013 to 2019.
- how: Outcomes Source population Outcomes were identified using ICD-coded hospital discharge . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.